1. Home
  2. SNCR vs BNTC Comparison

SNCR vs BNTC Comparison

Compare SNCR & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.46

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$12.31

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
BNTC
Founded
2000
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
405.7M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SNCR
BNTC
Price
$8.46
$12.31
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$28.25
AVG Volume (30 Days)
297.0K
244.5K
Earning Date
11-04-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$170,909,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.98
$9.70
52 Week High
$12.85
$17.15

Technical Indicators

Market Signals
Indicator
SNCR
BNTC
Relative Strength Index (RSI) 74.44 47.13
Support Level $8.22 $9.93
Resistance Level $8.46 $12.99
Average True Range (ATR) 0.17 1.00
MACD 0.04 -0.04
Stochastic Oscillator 90.17 64.53

Price Performance

Historical Comparison
SNCR
BNTC

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: